3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia
11
Prostatic Neoplasms
9
Breast Neoplasms
9
Leukemia, Myeloid, Acute
8
Leukemia, Lymphocytic, Chronic, B-Cell
7
Neuroblastoma
6
Myelodysplastic Syndromes
6
Multiple Myeloma
6
Melanoma
6
Lymphoma
6
Glioblastoma
6
Ovarian Neoplasms
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Glioma
4
Osteosarcoma
3
Neoplasm Metastasis
3
Lymphoma, Non-Hodgkin
3
Kidney Neoplasms
3
Fallopian Tube Neoplasms
3
Breast Neoplasms, Male
3
Neoplasms, Plasma Cell
2
Neoplasms
2
Medulloblastoma
2
Hodgkin Disease
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Wilms Tumor
1
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Interventions
Rituximab
134
Cyclophosphamide
100
Vincristine
53
fludarabine phosphate
50
Prednisone
50
Doxorubicin
49
Etoposide
47
Peripheral Blood Stem Cell Transplantation
38
Mycophenolic Acid
37
Whole-Body Irradiation
35
Tacrolimus
29
Busulfan
27
Lenalidomide
26
Filgrastim
26
Cyclosporine
26
Melphalan
24
Methotrexate
21
Antilymphocyte Serum
21
Gemcitabine
18
ibritumomab tiuxetan
17
Granulocyte Colony-Stimulating Factor
17
Cytarabine
17
Carmustine
16
Radiotherapy
15
fludarabine
14
Carboplatin
14
Bendamustine Hydrochloride
14
pembrolizumab
13
ibrutinib
12
Sirolimus
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, Large B-Cell, Diffuse
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
Clear all
No trials found.